全球膀胱癌治療及診斷市場 - 各種類、地區(2017年∼2022年)
Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||353865|
|出版日期||內容資訊||英文 115 Pages
|全球膀胱癌治療及診斷市場 - 各種類、地區(2017年∼2022年) Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年05月01日||內容資訊: 英文 115 Pages||
The bladder cancer therapeutics and diagnostics market will show rapid growth due to increasing awareness about bladder diseases and available therapies, increasing healthcare expenditure and innovations in drug development. There has been a rapid increase in the overall healthcare expenditure globally over the past few years. Therefore there are new medical technologies, treatments, and medicines available for these bladder cancer diseases that contribute majorly in the overall rise in the healthcare costs. The high drug prices, drug patent expiry, and cost of healthcare services account for two-thirds of the rise in healthcare spending. The expenditure on increased services, which includes costs of labor and productivity (in biopharmaceutical industries) is also one of the major factors driving the healthcare costs.
In addition, the growing research in the development of innovative bladder cancer therapies and the presence of pipeline therapeutics are further propelling the growth of the bladder cancer therapeutics market. Furthermore, the rise in awareness about bladder cancer and their available therapies, growing smoking and tobacco consumption are also motivating the market.
As per the scope of the report, bladder cancer is a tumor, which starts in the cells of the bladder. Bladder cancer is the rapid, uncontrolled growth of abnormal cells in the urinary bladder lining with epithelial cells. These cancerous cells may even spread through the lining into the muscular wall of the bladder. At present, a number of therapies have evolved to treat bladder cancers, which in turn build a high demand for the bladder cancer therapeutics market.
Cystoscopy is Anticipated to be the Dominant Segment in Diagnostics during the Forecast Period
Cystoscopy is a procedure used to see the interiors of the bladder and urethra using a telescope. A cystoscope is a specialized endoscope that is inserted through the urethra into the bladder to allow direct visual inspection of the urothelium. Cystoscopy is thus cost-effective, though, in combination with other tests, the cost varies. There are approximately 1.2 million flexible cystoscopy procedures conducted annually in the United States, and thus the introduction of Cysview is boosting the growth of the market and is expected to record a higher growth rate, during the forecast period.
North America Region Holds the Largest Market Share of Bladder Therapeutics And Diagnostics Market
The ecosystem for research and development for drugs for cancer is well established in North America, particularly in the US. Additionally, the presence of a large number of biologics companies and biopharmaceutical companies is contributing to the large size and excellent growth of bladder cancer therapeutics and diagnostics market.
North America also has the best adoption rates of new diagnostic modalities that are introduced in commercial space. This trend is in contrast with other regions of the world where the most widely adopted technologies for cancer diagnostics are at least a decade old. Consequently, North America is a leader in terms of the market size in the global bladder therapeutics and diagnostics market.
The major companies active in the market are AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Epocrates, Genentech, GlaxoSmithKline, Roche, Merck & Co, Novartis, Pfizer and so on. The companies present in the market are found focusing on product innovations, expansions, finding new markets or innovating their core competency to expand their individual market share.